Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


11th World Congress and Expo on Cell & Stem Cell Research

Hong Kong, China

Azzah Momenh

Azzah Momenh

National Institutes of Health, USA

Title: Protein Stabilization and Purification by Targeted domain swapping


Biography: Azzah Momenh


O-GlcNAcylation is a dynamic post-translational modification (PTM) of thousands of nuclear, cytoplasmic and mitochondrial proteins. This PTM targets serine or threonine residues of proteins, resulting in crosstalk with phosphorylation. The protein phosphorylation is controlled by many different kinases and phosphatases, whereas only two enzymes regulate O-GlcNAcylation. The addition of N-Acetylglucosamine onto target proteins is controlled by O-GlcNActransferase(OGT), while removal of this molecule is catalyzed by O-GlcNAcase(OGA). OGT uses UDP-GlcNAc(uridine diphosphate-N-acetylglucosamine) as a donor, which is the product of the hexosamine biosynthetic pathway. Since, nutrient derivative molecules, including glucose, glutamine, acetyl CoA and uridine diphosphate are all used to synthesize UDP-GlcNAc, O-GlcNAc cycling is susceptible to cellular nutrient levels. Therefore, O-GlcNAc is suggested to connect the nutrient status to cellular machineries. Moreover, O-GlcNAc cycling is involved in many fundamental functions, including transcription, translation, cell signaling, and protein trafficking. Deregulation of O-GlcNAcylation dynamics is involved in the etiology of diverse pathologies, such as type 2-diabetes, Alzheimer and cancers.